Physician

Timothy S Shaver, MD

According to 2025 Medicare claims, Timothy Shaver, MD (NPI: 1336145804) practices rheumatology in the Wichita, KS market, with the plurality of this provider's patient population coming from Sedgwick, KS. This provider's primary affiliated billing organization is ARTHRITIS AND RHEUMATOLOGY CLINICS OF KANSAS LLC (NPI: 1700881646; TIN: 431899877) and primary practice location at 67206-3405. Shaver is affiliated with the Aledade 38 KS CHC MSSP Enhanced (ACO ID: A4546) and Vytalize Health KS 25 LLC (ACO ID: A5671), participating under the MSSP model.

Shaver's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,110 traditional Medicare patients, billed 300,856 HCPCS/CPT codes, and received $3,215,002 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 7,628 prescription claims across 892 beneficiaries totaling $4,270,733 in drug costs, led by Humira(Cf) Pen (Adalimumab). 2020 DME data shows 33 claims. Open Payments data shows 216 records totaling $5,964. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $1,530,960 to $4,270,733. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $5,229 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	978	120,185	$2,308,043
2016	1,081	119,992	$2,505,825
2017	1,043	141,703	$2,776,779
2018	1,143	179,219	$3,066,686
2019	1,086	188,534	$3,337,629
2020	1,023	209,843	$3,379,862
2021	1,008	226,444	$3,494,515
2022	951	244,386	$2,995,475
2023	994	283,859	$3,189,200
2024	1,110	300,856	$3,215,002

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	677	6,315	$1,530,960
2016	682	6,414	$2,279,131
2017	703	6,393	$2,826,684
2018	737	6,365	$2,879,873
2019	738	6,292	$4,039,880
2020	772	6,699	$4,803,846
2021	784	6,968	$3,432,577
2022	764	6,541	$3,274,857
2023	773	6,735	$3,567,262
2024	892	7,628	$4,270,733

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	38	$85,284
2016	N/R	39	$85,335
2017	N/R	50	$68,592
2018	11	53	$71,272
2019	N/R	39	$67,922
2020	N/R	33	$57,316
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	550	870	$60
80053	Blood test, comprehensive group of blood chemicals	433	718	$10
36415	Insertion of needle into vein for collection of blood sample	456	620	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	438	752	$8
85652	Red blood cell sedimentation rate, to detect inflammation, automated	400	679	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	82	2,808	$670,266
Enbrel Sureclick	Etanercept	43	1,428	$378,837
Cosentyx Sensoready (2 Pens)	Secukinumab	42	1,176	$334,858
Otezla	Apremilast	60	1,800	$305,087
Rinvoq	Upadacitinib	45	1,440	$303,573

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	216	$5,964	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Timothy S. Shaver, MD?

Tedicare shows public-source Medicare data for Timothy S. Shaver, MD (NPI 1336145804), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Timothy S. Shaver, MD have ACO affiliation data?

Timothy S. Shaver, MD is shown with ACO affiliation data for Aledade 38 KS CHC MSSP Enhanced (MSSP, ACO ID A4546) and Vytalize Health KS 25 LLC (MSSP, ACO ID A5671).

What billing organization is linked to Timothy S. Shaver, MD?

Timothy S. Shaver, MD is linked to ARTHRITIS AND RHEUMATOLOGY CLINICS OF KANSAS LLC (billing NPI 1700881646) in the available physician profile data.

Does Timothy S. Shaver, MD have Open Payments data?

Timothy S. Shaver, MD has 216 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.